Benzinga | Feb 26, 2021 09:44AM EST

Roth Capital Initiates Coverage On Amyris with Buy Rating, Announces Price Target of $20

Roth Capital analyst Craig Irwin initiates coverage on Amyris (NASDAQ:AMRS) with a Buy rating and announces Price Target of $20.